Nathan SD - Search Results

1

Contemporary optimized practice in the management of pulmonary sarcoidosis.

Aryal S, Nathan SD. Aryal S, et al. Among authors: nathan sd. Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619868935. doi: 10.1177/1753466619868935. Ther Adv Respir Dis. 2019. PMID: 31409257 Free PMC article. Review.

2

Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.

Nathan SD, Noble PW, Tuder RM. Nathan SD, et al. Am J Respir Crit Care Med. 2007 May 1;175(9):875-80. doi: 10.1164/rccm.200608-1153CC. Epub 2007 Jan 25. Am J Respir Crit Care Med. 2007. PMID: 17255562 Review.

3

Pulmonary hypertension in interstitial lung disease.

Nathan SD. Nathan SD. Int J Clin Pract Suppl. 2008 Jul;(160):21-8. doi: 10.1111/j.1742-1241.2008.01624.x. Int J Clin Pract Suppl. 2008. PMID: 18720579 Review.

4

Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience.

Barnett CF, Bonura EJ, Nathan SD, Ahmad S, Shlobin OA, Osei K, Zaiman AL, Hassoun PM, Moller DR, Barnett SD, Girgis RE. Barnett CF, et al. Among authors: nathan sd. Chest. 2009 Jun;135(6):1455-1461. doi: 10.1378/chest.08-1881. Epub 2008 Dec 31. Chest. 2009. PMID: 19118270 Free PMC article.

5

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis.

Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, Burton N, Barnett SD. Nathan SD, et al. Respir Med. 2010 Jul;104(7):1035-41. doi: 10.1016/j.rmed.2010.02.008. Epub 2010 Mar 2. Respir Med. 2010. PMID: 20199856 Free article.

6

Pulmonary hypertension secondary to interstitial lung disease.

Shlobin OA, Nathan SD. Shlobin OA, et al. Among authors: nathan sd. Expert Rev Respir Med. 2011 Apr;5(2):179-89. doi: 10.1586/ers.11.11. Expert Rev Respir Med. 2011. PMID: 21510729 Review.

7

Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation.

Shlobin OA, Nathan SD. Shlobin OA, et al. Among authors: nathan sd. Eur Respir J. 2012 Jun;39(6):1520-33. doi: 10.1183/09031936.00175511. Epub 2012 Jan 12. Eur Respir J. 2012. PMID: 22241743 Free article. Review.

8

Pulmonary hypertension due to lung disease and/or hypoxia.

Nathan SD, Hassoun PM. Nathan SD, et al. Clin Chest Med. 2013 Dec;34(4):695-705. doi: 10.1016/j.ccm.2013.08.004. Epub 2013 Oct 17. Clin Chest Med. 2013. PMID: 24267299 Review.

9

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis.

Nathan SD, du Bois RM, Albera C, Bradford WZ, Costabel U, Kartashov A, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE Jr. Nathan SD, et al. Respir Med. 2015 Jul;109(7):914-22. doi: 10.1016/j.rmed.2015.04.008. Epub 2015 Apr 24. Respir Med. 2015. PMID: 25956020 Free article. Clinical Trial.

10

Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.

Raghu G, Nathan SD, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Wells AU, Shao L, Zhou H, Henig N, Szwarcberg J, Gillies H, Montgomery AB, O'Riordan TG. Raghu G, et al. Among authors: nathan sd. Eur Respir J. 2015 Nov;46(5):1370-7. doi: 10.1183/13993003.01537-2014. Epub 2015 Aug 6. Eur Respir J. 2015. PMID: 26250495 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters